PHM
48
-16
PGR
38
-21
NSC
54
-19
FRT
55
-17
IFF
65
-13
FAST
52
-17
SYK
44
-27
MMC
51
-24
L
54
-6
AKAM
48
5
A
62
2
PEG
37
-30
APA
49
4
MTCH
59
-21
SPG
48
-25
CHD
39
-25
PNR
62
-16
AEP
62
-2
AEE
60
-4
MAR
63
-17
PHM
48
-16
PGR
38
-21
NSC
54
-19
FRT
55
-17
IFF
65
-13
FAST
52
-17
SYK
44
-27
MMC
51
-24
L
54
-6
AKAM
48
5
A
62
2
PEG
37
-30
APA
49
4
MTCH
59
-21
SPG
48
-25
CHD
39
-25
PNR
62
-16
AEP
62
-2
AEE
60
-4
MAR
63
-17
Financhill
Back

Macrogenics 10K Form

Sell
37

MGNX
Macrogenics

Last Price:
$1.60
Seasonality Move:
-11.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09 10Q MGNX/Macrogenics Quarterly
2023-11-06 10Q MGNX/Macrogenics Quarterly
2023-08-09 10Q MGNX/Macrogenics Quarterly
2023-05-09 10Q MGNX/Macrogenics Quarterly
2022-11-03 10Q MGNX/Macrogenics Quarterly
2022-08-08 10Q MGNX/Macrogenics Quarterly

Receive MGNX News And Ratings

See the #1 stock for the next 7 days that we like better than MGNX

MGNX Financial Statistics

Sales & Book Value

Annual Sales: $148.3M
Cash Flow: $-47.4M
Price / Cash Flow: 0
Annual Sales: $1.25
Price / Book: 1.17

Profitability

EPS (TTM): -0.89000
Net Income (TTM): $-55.8M
Gross Margin: $136M
Return on Equity: -58.23%
Return on Assets: -23.25%

Macrogenics Earnings Forecast

Key Macrogenics Financial Ratios

  • The Gross Profit Margin over the past 10 years for MGNX is 91.71%.
  • The Selling, General & Administrative Expenses for MGNX have been equal to 47.90% of Gross Profit Margin.
  • The Research & Development expenses have been 119.45% of Revenue.
  • The Net Earning history of MGNX is -45.14% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 7 years.

Macrogenics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MGNX
CUSIP: 556099
Website: macrogenics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.28
Quick Ratio: 2.97

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MGNX Technical Analysis vs Fundamental Analysis

Sell
37
Macrogenics (MGNX) is a Sell

Is Macrogenics a Buy or a Sell?

  • Macrogenics stock is rated a Sell
    The current Macrogenics [MGNX] share price is $1.47. The Score for MGNX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.